•  Free Webinar - FDA QMSR Inspection Readiness: What Early Form 483 Observations May Reveal
  • Free Webinar - FDA QMSR Inspection Readiness: What Early Form 483 Observations May Reveal

    • Speaker : Amorit Education
    • Session Code : AEMAY1926
    • Date : May 2026
    • Time : N/A
    • Duration : 20 Mins

 Scroll to the bottom to watch the entire 20 mins explainer


Overview:

 

FDA’s Quality Management System Regulation (QMSR) is now in effect, and medical device companies are beginning to face the practical inspection realities that come with the shift from QSR to QMSR. This free webinar explains what quality, regulatory, supplier, CAPA, complaint, UDI, labeling, and manufacturing teams should understand as early QMSR inspection activity begins to reveal practical readiness signals.

 

The session focuses on how medical device companies can prepare before an FDA investigator arrives. It is not just about updating procedures or aligning documents with ISO 13485:2016. The bigger question is whether the company can show that its quality system is working in daily operations.

 

The quick webinar walks through practical inspection themes involving risk management, supplier controls, complaint handling, MDR evaluation, UDI and traceability, CAPA, internal audits, management review, and quality culture. It also explains why QMSR readiness should be treated as a cross-functional responsibility, not something owned only by QA or regulatory affairs.

 

Areas Covered:


  • What changed from QSR to QMSR
  • Why QMSR is more than a paperwork update
  • How QMSR aligns FDA medical device quality requirements with ISO 13485:2016
  • Why early Form 483 observations should be treated as inspection signals
  • What FDA investigators may expect to see during QMSR inspections
  • How risk management should connect across the quality system
  • Supplier control expectations for outsourced activities
  • Why companies can outsource work but not quality responsibility
  • Complaint handling as regulatory and post-market quality data
  • How complaint files should connect to MDR, CAPA, risk review, and trend analysis
  • UDI and traceability expectations for complaints, investigations, and recall readiness
  • CAPA expectations around root cause, corrective action, and effectiveness checks
  • Internal audit and management review record readiness
  • Why audit findings should be factual, specific, and evidence-based
  • Common documentation mistakes that can create inspection risk
  • Quality culture and cross-functional escalation
  • Practical readiness questions for QA, regulatory affairs, supplier quality, complaint handling, CAPA owners, manufacturing, and leadership


Why Should You Watch This Webinar?

 

QMSR is already in effect, which means medical device companies should move beyond general awareness and begin checking whether their quality system can stand up during a real inspection. A procedure may exist, but FDA investigators may look for evidence that the process is being used, connected, reviewed, and improved in actual operations.

 

This webinar helps quality and regulatory teams understand where inspection pressure may appear first: risk files, supplier files, complaint records, MDR evaluations, UDI capture, CAPA records, internal audit reports, and management review documentation. These are areas where weak documentation can make a company look unprepared even when the underlying process exists.

 

The practical value of this video is that it turns QMSR readiness into a working checklist. Viewers will understand what different teams should review, what records should explain clearly, and how to connect quality system evidence before inspection findings become harder to manage.

 

Who Will Benefit?

 

This video is designed for medical device professionals involved in quality system readiness, inspection preparation, product risk, supplier oversight, complaint handling, corrective action, regulatory reporting, labeling, traceability, and management review. Those include:

 

  • Quality Assurance Managers/Quality Systems Managers
  • Regulatory Affairs Managers/Regulatory Affairs Specialists
  • Supplier Quality Managers/Supplier Quality Engineers
  • CAPA Owners/Complaint Handling Teams
  • Post-Market Surveillance Teams/MDR Reporting Teams
  • UDI and Labeling Teams/Manufacturing Quality Managers
  • Quality Engineers/Design Quality Engineers
  • Operations Managers/Production Managers
  • Internal Audit Teams/Management Review Coordinators
  • Compliance Officers/Medical Device Executives
  • Quality Directors/Regulatory Directors
  • Inspection Readiness Teams/Medical Device Consultants
  • ISO 13485 Compliance Professionals


Watch the entire 20 mins explainer here:




This webinar is presented by Amorit Education’s in-house experts, who closely monitor FDA regulatory, compliance, quality system, and industry developments affecting medical device, pharmaceutical, biotechnology, and other life sciences organizations. Their work is focused on turning complex FDA and regulatory updates into practical guidance that helps quality, regulatory, compliance, operations, and business teams understand what has changed, why it matters, where risks may emerge, and what actions may deserve closer attention.

 

For this session, the focus is on helping medical device professionals understand the practical impact of QMSR, including how quality systems, risk management, supplier oversight, complaint handling, CAPA, UDI, internal audits, and management review may need to work together under current FDA expectations.

Write a review

Please login or register to review

Tags: FDA Compliance, QMSR, Medical Devices, Form 483, FDA Inspection, Inspection Readiness, ISO 13485, Quality Management System, CAPA, Supplier Quality, Complaint Handling, MDR, UDI, Risk Management, Regulatory Affairs, Quality Assurance, Internal Audits, Management Review, Medical Device Compliance, Quality Systems